Cargando…
A double-blind randomized clinical trial of Dracocephalum kotschyi Boiss. in the patients with diarrhea-predominant irritable bowel syndrome
BACKGROUND AND PURPOSE: Irritable bowel syndrome (IBS) is a disease that shows its impacts on many populations worldwide. It is known as a functional disorder of the gastrointestinal tract followed by diarrhea and fecal inconsistency. Due to the lack of treatment in the allopathic medicine system fo...
Autores principales: | Heydari, Parisa, Ghanadian, Mustafa, Asghari, Gholamreza, Azimi, Maryam, Babaeian, Mahmoud, Adibi, Peyman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951779/ https://www.ncbi.nlm.nih.gov/pubmed/36846732 http://dx.doi.org/10.4103/1735-5362.363599 |
Ejemplares similares
-
Medicinal Properties and Active Constituents of Dracocephalum kotschyi and Its Significance in Iran: A Systematic Review
por: Heydari, Parisa, et al.
Publicado: (2019) -
Corrigendum to “Medicinal Properties and Active Constituents of Dracocephalum kotschyi and Its Significance in Iran: A Systematic Review”
por: Heydari, Parisa, et al.
Publicado: (2019) -
Antidiarrhoeal assessment of hydroalcoholic and hexane extracts of Dracocephalum kotschyi Boiss. and apigenin in mice
por: Sadraei, Hassan, et al.
Publicado: (2016) -
Comparison of antispasmodic effect of hydroalcoholic extract of Dracocephalum kotschyi Boiss. in rat uterus and ileum
por: Sadraei, Hassan, et al.
Publicado: (2016) -
Toward understanding of the methoxylated flavonoid biosynthesis pathway in Dracocephalum kotschyi Boiss
por: Poursalavati, Abdonaser, et al.
Publicado: (2021)